Languages
- Arabic, English, Persian
Contact us
Please feel welcome to contact our friendly reception staff with any general or medical enquiry call us.
Biography
Dr. Asad Abdi is an experienced Neurology Specialist with over 20 years of clinical experience in diagnosing and managing a wide range of neurological disorders.
He specializes in the evaluation and treatment of conditions including stroke, epilepsy, headaches, movement disorders, memory problems, neuromuscular diseases, and disorders of the brain, spine, and peripheral nerves.
Dr. Abdi also has strong experience in neurophysiological investigations such as EEG and EMG, and is known for his accurate diagnosis, patient-centered approach, and evidence-based treatment planning.
He is a member of the American Academy of Neurology and is licensed to practice in the UAE.
Speciality
Specialist Neurologist
Areas of Expertise
- Neurology Specialist
- Stroke & Neurovascular Disorders
- Epilepsy & Seizure Disorders
- Headache & Migraine Management
- Movement Disorders
- Memory & Cognitive Disorders
- Peripheral Neuropathy
- Neuromuscular Diseases (including Myasthenia Gravis)
- Spine & Spinal Cord Disorders
Education
- MD – Yazd University of Medical Sciences, Iran
- Specialty in Neurology – Kerman University of Medical Sciences, Iran
- Neurology Residency – Shafa Hospital, Kerman, Iran
Core Competencies
- Neurological Examination & Clinical Diagnosis
- EEG & EMG Interpretation
- Neurophysiology Assessment
- Stroke & Emergency Neurology Care
- Chronic Neurological Disease Management
- Patient Counselling & Education
- Multidisciplinary Collaboration
- Evidence-Based Treatment Planning
- Strong Clinical Decision-Making
- Patient Safety & Ethical Care
Publications
- Abdi A, et al. Tirzepatide associated autoimmune encephalitis: A case report. 2025
- Abdi A, et al. White matter changes in dementia disorders: Systematic review. 2025
- Hatamian S, Abdi A, et al. Calcium channel blockers in stroke outcomes. 2025
- Abdi A, et al. Epilepsy SEEG center development in Iran. 2025